SOD2 and cancer: In cancer cells, similarly to the reduction of ATP production, the decrease of mitochondrial ROS formation is also significant, in which SIRT3 has been proved to play a pivotal role by the deacetylation and activation of superoxide dismutase 2 (SOD2) enzyme (52).